Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.10.15	Pfizer Confirms Preliminary Merger Talks With Allergan - Quick Facts (RTTNews)
29.10.15	Allergan Confirms Talks On Potential Combination With Pfizer - Quick Facts (RTTNews)
29.10.15	Report : Pfizer And Allergan Consider Merger (RTTNews)
27.10.15	Allergan Acquires Rights To CONSTELLA In More Than 40 Countries - Quick Facts (RTTNews)
12.10.15	LLY Fixing Depleted Pipeline, AMGN's Prolia Outdoes Rival, Opdivo In The News (RTTNews)
09.10.15	Allergan Says FDA Accepts Supplemental New Drug Application For DALVANCE (RTTNews)
05.10.15	Avita Back In News, GILD Gets FDA Thumbs Up, HZNP Settles Rayos Patent Suit (RTTNews)
02.10.15	Allergan, Humana In Research Partnership To Improve Health Outcomes (RTTNews)
28.09.15	Allergan Updates H2 Continuing Operations Forecast (RTTNews)
23.09.15	Amgen: ABP 215 Shows Clinical Equivalence To Bevacizumab In Phase 3 Study (RTTNews)
22.09.15	AGN, IPXL In Legal Bout, ANIP Opens Wallet, PFE's Octave Hits Right Notes (RTTNews)
21.09.15	Allergan Inc. Confirms Generic Rytary Patent Challenge - Quick Facts (RTTNews)
18.09.15	Allergan : FDA Approves New Drug To Treat Schizophrenia And Bipolar Disorder (RTTNews)
10.09.15	Allergan Announces Settlement With Amneal Related To NAMENDA Patent Litigation (RTTNews)
04.09.15	AGN Opens Wallet Yet Again, VTL Trims Workforce, First Biosimilar Launched (RTTNews)
03.09.15	Allergan To Buy Glaucoma Treatment Company For $300, Plus Milestones (RTTNews)
02.09.15	Allergan: Positive Phase III Studies Further Support AVYCAZ - Quick Facts (RTTNews)
02.09.15	Allergan: FDA Approves Updated Label For TEFLARO - Quick Facts (RTTNews)
12.08.15	Allergan Confirms Generic Noxafil Patent Challenge (RTTNews)
06.08.15	Allergan Q2 Profit Tops Estimates - Quick Facts (RTTNews)
06.08.15	New Styles Added To AGN's Natrelle Line, MGNX Has Macro Plans, ALDR Awaits Data (RTTNews)
30.07.15	Allergan Confirms Generic Tyvaso Patent Challenge - Quick Facts (RTTNews)
27.07.15	Teva To Buy Allergan Generics For $40.5 Bln Cash, Stock; Shares Up (RTTNews)
27.07.15	Teva To Buy Allergan Generics For $40.5 Bln; Withdraws Offer For Mylan (RTTNews)
27.07.15	Allergan To Acquire Naurex For $560 Mln In Cash (RTTNews)
26.07.15	WSJ: Teva In Talks To Buy Allergan's Generic Drug Unit For About $45 Bln (RTTNews)
07.07.15	Allergan To Acquire Worldwide Rights To Merck's Migraine Development Program (RTTNews)
06.07.15	Allergan To Acquire Oculeve In All-cash Deal - Quick Facts (RTTNews)
17.06.15	Allergan To Buy Kythera Biopharma For $2.1 Bln (RTTNews)
17.06.15	So Long, KYTHERA (RTTNews)
17.06.15	Allergan To Acquire KYTHERA Biopharma For $75 Per KYTHERA Share - Quick Facts (RTTNews)
16.06.15	Allergan Says FDA Extended Review Period For Cariprazine To Sept. 2015 (RTTNews)
06.04.15	Icon Bioscience Reports Phase 3 Data For IBI-10090 - Quick Facts (RTTNews)
19.03.15	Philips Proposes Former Allergan CEO David Pyott As Supervisory Board Member (RTTNews)
17.03.15	Actavis Closes Acquisition Of Allergan - Quick Facts (RTTNews)
17.03.15	American Airlines Group To Replace Allergan In S&P 500 (RTTNews)
16.03.15	European Commission Okays Actavis' Pending Acquisition Of Allergan (RTTNews)
10.03.15	Actavis, Allergan Shareholders Okay Merger Proposals (RTTNews)
04.03.15	Actavis Prices Offering Of $21 Bln Of Senior Unsecured Notes (RTTNews)
02.03.15	AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal (RTTNews)
27.02.15	FDA Okays Allergan's Natrelle Inspira Round Gel-Filled Breast Implants (RTTNews)
22.02.15	Reports: Valeant Nears Deal To Buy Salix Pharma For About $10 Bln (RTTNews)
18.02.15	Actavis Plans To Adopt "Allergan" Corporate Name - Quick Facts (RTTNews)
04.02.15	Allergan Profit Crushes Estimate (RTTNews)
12.01.15	Actavis-Allergan Deal Gets U.S. Antitrust Approval - Quick Facts (RTTNews)
25.11.14	Bloomberg: Actavis Plans To Cut Jobs, Expand In China (RTTNews)
19.11.14	Ackman's Pershing Square Withdraws Call For Allergan Special Shareholder Meeting (RTTNews)
18.11.14	ACT Buys AGN, NBS Needs A Close Watch, No Pain For TRVN, TKMR Does A Deal (RTTNews)
17.11.14	Actavis To Acquire Allergan In $66 Bln Deal (RTTNews)
17.11.14	Valeant Pharma Issues Statement On Allergan Announcement - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
26.11.24		Börse New York: Dow Jones wenig verändert
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Börse Zürich: SMI letztendlich in Rot
26.11.24		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
26.11.24		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?
26.11.24		Schwacher Handel in New York: Dow Jones zum Start mit Abgaben

26.11.24

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

26.11.24

Börse New York: Dow Jones wenig verändert

26.11.24

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

26.11.24

Börse Zürich: SMI letztendlich in Rot

26.11.24

S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen

26.11.24

Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?